Norges Bank Mimedx Group, Inc. Transaction History

Norges Bank

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.16 - $8.08 $433,664 - $568,832	70,400 New	70,400 $487,000
Q4 2023 Feb 09, 2024	BUY	$5.7 - $9.14 $2.79 Million - $4.47 Million	489,000 New	489,000 $4.29 Million
Q3 2023 Nov 13, 2024	BUY	$6.35 - $8.16 $3.2 Million - $4.11 Million	503,700 New	503,700 $3.67 Million
Q4 2018 Mar 04, 2019	BUY	$1.15 - $6.45 $461,491 - $2.59 Million	401,297 New	401,297 $718,000
Q4 2018 Feb 08, 2019	SELL	$1.15 - $6.45 $1.73 Million - $9.68 Million	-1,500,889 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$3.22 - $6.33 $4.83 Million - $9.5 Million	1,500,889 New	1,500,889 $9.28 Million
Q3 2018 Nov 09, 2018	SELL	$3.22 - $6.33 $4.83 Million - $9.5 Million	-1,500,889 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$5.39 - $8.96 $8.09 Million - $13.4 Million	1,500,889 New	1,500,889 $9.59 Million
Q2 2018 Jul 23, 2018	SELL	$5.39 - $8.96 $8.09 Million - $13.4 Million	-1,500,889 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$6.69 - $17.96 $10 Million - $27 Million	1,500,889 New	1,500,889 $10.5 Million
Q1 2018 May 09, 2018	SELL	$6.69 - $17.96 $8.09 Million - $21.7 Million	-1,209,183 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$10.87 - $13.9 $13.1 Million - $16.8 Million	1,209,183 New	1,209,183 $15.2 Million
Q4 2017 Feb 09, 2018	SELL	$10.87 - $13.9 $9.84 Million - $12.6 Million	-905,633 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$11.86 - $17.34 $10.7 Million - $15.7 Million	905,633	905,633 $10.8 Million

208

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.03B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.